Related Experiment Videos

Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a

AbdolMohammad Kajbafzadeh1, Amir Hassan Mahboubi, Seyedmehdi Payabvash

  • 1Paediatric Urology Research Center, Department of Urology, Children's Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

BJU International
|January 22, 2009
PubMed

Insights

This study shows that combining botulinum toxin-type A (BTX-A) injections with laparoscopic antegrade continence enema (LACE) effectively treats bladder and bowel dysfunction in children with myelomeningocele, leading to improved continence and urodynamic function.

Area of Science:

  • Pediatric Urology
  • Minimally Invasive Surgery
  • Neurogenic Bladder and Bowel Dysfunction

Background:

  • Children with myelomeningocele often experience complex bladder and bowel dysfunction.
  • Previous treatments like botulinum toxin-type A (BTX-A) injections may not fully resolve fecal incontinence or constipation.
  • Laparoscopic antegrade continence enema (LACE) offers a surgical approach for bowel management.

Purpose of the Study:

  • To evaluate the efficacy of simultaneous laparoscopic antegrade continence enema (LACE) and repeated intravesical botulinum toxin-type A (BTX-A) injections.
  • To assess the combined impact on bladder and bowel dysfunction in pediatric myelomeningocele patients.
  • To report surgical outcomes and patient continence status.

Main Methods:

  • A cohort of 20 children (mean age 8.7 years) with myelomeningocele and persistent fecal incontinence/constipation underwent the combined procedure.
  • Laparoscopic appendicostomy (LACE) was performed following repeated intravesical BTX-A injections.
  • Urodynamic studies and assessment of urinary/bowel continence were conducted post-procedure.

Main Results:

  • Significant improvement in urinary continence was observed, with 95% of children becoming nappy-free.
  • Urodynamic parameters including maximum detrusor pressure, bladder compliance, and capacity showed significant improvement (P < 0.001).
  • The combined BTX-A and LACE procedure demonstrated superior urodynamic outcomes compared to BTX-A alone, with good tolerability and minimal complications.

Conclusions:

  • Simultaneous repeat intravesical BTX-A injections and LACE provide an effective management strategy for bladder and bowel dysfunction in children with myelomeningocele.
  • This combined approach can enhance bladder urodynamic function by facilitating effective bowel evacuation.
  • The procedure offers a promising solution for improving quality of life in this patient population.
Abstract

Related Concept Videos

Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...